Rezumat articol ediţie STUDIA UNIVERSITATIS BABEŞ-BOLYAI

În partea de jos este prezentat rezumatul articolului selectat. Pentru revenire la cuprinsul ediţiei din care face parte acest articol, se accesează linkul din titlu. Pentru vizualizarea tuturor articolelor din arhivă la care este autor/coautor unul din autorii de mai jos, se accesează linkul din numele autorului.

 
       
         
    STUDIA CHEMIA - Ediţia nr.2, Tom I din 2017  
         
  Articol:   VALIDATED LC-MS/MS METHOD FOR THE CONCOMITANT DETERMINATION OF AMOXICILLIN AND CLAVULANIC ACID FROM HUMAN PLASMA.

Autori:  JÓZSEF BALÁZSI, CSABA PAIZS, FLORIN-DAN IRIMIE, MONICA IOANA TOŞA, LÁSZLÓ CSABA BENCZE, RÓBERT TŐTŐS.
 
       
         
  Rezumat:  
DOI: https://doi.org/10.24193/subbchem.2017.2.12

Published Online: 2017-06-20
Published Print: 2017-06-30

VIEW PDF: VALIDATED LC-MS/MS METHOD…

The purpose of this study was the development and validation of an LC-MS/MS method, for the concomitant and rapid determination amoxicillin and clavulanic acid from human plasma. The sample workup involved a simple protein precipitation procedure. A core/shell type analytical column (50×2,1 mm, 2.6 Å) was used with PFP stationary phase. A mobile phase with high aqueous composition provided satisfactory separation with good accuracy and precision (stable ionization). The mass spectrometer was operated in positive electrospray ionization mode for both analytes and internal standard. The following parameters were evaluated for validation purpose: Selectivity, sensitivity, matrix effect, anticoagulant effect, linearity, precision and accuracy, recovery, analyte/IS stability in solvent/matrix and carryover. The validated calibration range was 190-22222 ng/ml for amoxicillin, and 147-4908 ng/ml for clavulanic acid. The correlation coefficient R2 was at least 0.99 for both analytes. The validated method has been successfully used for the evaluation bioequivalence of generic amoxicillin/potassium clavulanate formulations.

Keywords: amoxicillin, clavulanic acid, method validation, bioequivalence trial, LC-MS/MS
 
         
     
         
         
      Revenire la pagina precedentă